These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26995169)

  • 1. Radical red tape reduction by government supported nasal naloxone: the Norwegian pilot project is innovative, safe and an important contribution to further development and dissemination of take-home naloxone.
    Lobmaier PP; Clausen T
    Addiction; 2016 Apr; 111(4):586-7. PubMed ID: 26995169
    [No Abstract]   [Full Text] [Related]  

  • 2. Ethical issues and stakeholders matter.
    Dale O
    Addiction; 2016 Apr; 111(4):587-9. PubMed ID: 26995170
    [No Abstract]   [Full Text] [Related]  

  • 3. Ensure global access to naloxone for opioid overdose management.
    Balster RL; Walsh SL
    Addiction; 2016 Apr; 111(4):589-90. PubMed ID: 26995171
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?
    Strang J; McDonald R; Tas B; Day E
    Addiction; 2016 Apr; 111(4):574-82. PubMed ID: 26840916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal naloxone soon to become part of evolving clinical practice around opioid overdose prevention.
    Dietze P; Cantwell K
    Addiction; 2016 Apr; 111(4):584-6. PubMed ID: 26995168
    [No Abstract]   [Full Text] [Related]  

  • 6. Tangled-up and blue: releasing the regulatory chokehold on take-home naloxone.
    Winstanley EL
    Addiction; 2016 Apr; 111(4):583-4. PubMed ID: 26995167
    [No Abstract]   [Full Text] [Related]  

  • 7. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study.
    Seal KH; Thawley R; Gee L; Bamberger J; Kral AH; Ciccarone D; Downing M; Edlin BR
    J Urban Health; 2005 Jun; 82(2):303-11. PubMed ID: 15872192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Working together: Expanding the availability of naloxone for peer administration to prevent opioid overdose deaths in the Australian Capital Territory and beyond.
    Lenton S; Dietze P; Olsen A; Wiggins N; McDonald D; Fowlie C
    Drug Alcohol Rev; 2015 Jul; 34(4):404-11. PubMed ID: 25272281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges with take-home naloxone in reducing heroin mortality: a review of fatal heroin overdose cases in Victoria, Australia.
    Stam NC; Gerostamoulos D; Smith K; Pilgrim JL; Drummer OH
    Clin Toxicol (Phila); 2019 May; 57(5):325-330. PubMed ID: 30451007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The message from heroin overdoses].
    Pap Á; Hegedűs K
    Orv Hetil; 2015 Mar; 156(9):352-7. PubMed ID: 25702255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal naloxone administration by police first responders is associated with decreased opioid overdose deaths.
    Rando J; Broering D; Olson JE; Marco C; Evans SB
    Am J Emerg Med; 2015 Sep; 33(9):1201-4. PubMed ID: 26095132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid widespread distribution of intranasal naloxone for overdose prevention.
    Madah-Amiri D; Clausen T; Lobmaier P
    Drug Alcohol Depend; 2017 Apr; 173():17-23. PubMed ID: 28182982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal naloxone for life threatening opioid toxicity.
    Kelly AM; Koutsogiannis Z
    Emerg Med J; 2002 Jul; 19(4):375. PubMed ID: 12101174
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom.
    Langham S; Wright A; Kenworthy J; Grieve R; Dunlop WCN
    Value Health; 2018 Apr; 21(4):407-415. PubMed ID: 29680097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of concentrated naloxone nasal spray over first 30 minutes post-dosing: analysis of suitability for opioid overdose reversal.
    Mundin G; McDonald R; Smith K; Harris S; Strang J
    Addiction; 2017 Sep; 112(9):1647-1652. PubMed ID: 28430384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From Peers to Lay Bystanders: Findings from a Decade of Naloxone Distribution in Pittsburgh, PA.
    Bennett AS; Bell A; Doe-Simkins M; Elliott L; Pouget E; Davis C
    J Psychoactive Drugs; 2018; 50(3):240-246. PubMed ID: 29424656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heroin overdose resuscitation with naloxone: patient uses own prescribed supply to save the life of a peer.
    Winston I; McDonald R; Tas B; Strang J
    BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26370638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attitudes of Australian heroin users to peer distribution of naloxone for heroin overdose: perspectives on intranasal administration.
    Kerr D; Dietze P; Kelly AM; Jolley D
    J Urban Health; 2008 May; 85(3):352-60. PubMed ID: 18347990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Take-home emergency naloxone to prevent heroin overdose deaths after prison release: rationale and practicalities for the N-ALIVE randomized trial.
    Strang J; Bird SM; Parmar MK
    J Urban Health; 2013 Oct; 90(5):983-96. PubMed ID: 23633090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Distribution of naloxone to prevent death from heroin overdose. Study of opioid dependent patients' attitudes to be part of the antidote program].
    Håkansson A; Vedin A; Wallin C; Kral AH
    Lakartidningen; 2013 Jul 17-Aug 6; 110(29-31):1340-2. PubMed ID: 23980443
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.